Nuclera

Exhibitor

Nuclera is a biotechnology company dedicated to accelerating drug discovery by making high-quality proteins accessible to scientists worldwide.

The company's core technology is the eProtein Discovery™ System, a compact, benchtop platform that dramatically streamlines the process of protein expression and optimization. By integrating cell-free protein synthesis with novel digital microfluidics and cloud-based data analytics, the eProtein Discovery system replaces traditional trial-and-error methods with automated, multiplex screening.

This innovative system allows researchers to screen hundreds of construct and condition pairs in parallel to identify the optimal path to a successful protein in just 24 hours. It then facilitates the scale-up of assay-ready protein—including challenging targets like membrane proteins—to microgram-to-milligram quantities, often in less than 48 hours.

By providing rapid access to functional, purified proteins, Nuclera empowers biopharma, biotech, and academic researchers to accelerate target identification, quickly test feasibility, and confidently advance drug candidates, ultimately expediting breakthroughs in therapeutic development.